# Ulsan University Hospital

Organization · id `cardio:org-ulsan-university-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 03sab2a45](<https://ror.org/03sab2a45>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 03sab2a45 by an exact name.

## The registry's words

- Sponsor name: Ulsan University Hospital
- Sponsor class: OTHER
- ROR name: Ulsan University Hospital

## Connected pages

- Sponsors: The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension (`cardio:ct-nct01135212`)
- Sponsors: A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (`cardio:ct-nct01672476`)
- Sponsors: Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries (`cardio:ct-nct01903902`)
- Sponsors: Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease (`cardio:ct-nct01946815`)
- Sponsors: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (`cardio:ct-nct02056847`)
- Sponsors: Fimasartan/Amlodipine Combination Phase III (`cardio:ct-nct02152306`)
- Sponsors: Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction (`cardio:ct-nct02224534`)
- Sponsors: Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease (`cardio:ct-nct05846893`)
- Sponsors: Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions (`cardio:ct-nct07548281`)
- Sponsors: TRADENT Scoring Balloon Versus Non-scoring Balloon for Lesion Preparation in DCB-Based Coronary Intervention (`cardio:ct-nct07899021`)

## Provenance

Content hash: 47eb8fb2c82f3ad9aa544e23b2a7208968130389dc18185779efd8581be2b64f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
